bioAffinity Technologies, Inc. (BIAF) vs FibroBiologics, Inc. Common Stock (FBLG)
A side-by-side comparison of bioAffinity Technologies, Inc. and FibroBiologics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.19HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FBLG
FibroBiologics, Inc. Common Stock
$1.18HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BIAF vs FBLG
growth of $100 · dividends reinvested · last 3yBIAF -99.1% (-79.4%/yr)FBLG -99.8% (-87.3%/yr)BIAF compounded faster over this window
BIAF FBLG
BIAF vs FBLG: by the numbers
- •BIAF is the larger company ($3M vs $2M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | BIAF | FBLG |
|---|---|---|
| P/S ratio | 0.44 | N/A |
| P/B ratio | 0.69 | 0.53 |
Profitability
| Metric | BIAF | FBLG |
|---|---|---|
| Gross margin | 23.21% | 0.00% |
| Operating margin | -171.58% | 0.00% |
| Net margin | -257.33% | 0.00% |
| ROE | -402.92% | -391.26% |
| ROIC | -237.93% | -286.46% |
Go deeper
Dig into the metrics
bioAffinity Technologies ROEFibroBiologics, Inc. Common Stock ROEbioAffinity Technologies operating marginFibroBiologics, Inc. Common Stock operating marginbioAffinity Technologies revenue growthFibroBiologics, Inc. Common Stock revenue growthbioAffinity Technologies free cash flowFibroBiologics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.